The novel approach of tirzepatide peptide represents a exciting development in the handling of diabetes mellitus type 2. Different to existing drugs, tirzepatide targets two pathways – GLP-1 and the GIP hormone – https://tirzepatidepeptide845843.myparisblog.com/42565089/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment